SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001615774-18-007607
Filing Date
2018-08-06
Accepted
2018-08-06 16:32:02
Documents
2
Group Members
VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A s111903_sc13ga.htm SC 13G/A 95846
2 EXHIBIT 99.1 s111903_ex99-1.htm EX-99.1 4592
  Complete submission text file 0001615774-18-007607.txt   102026
Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Filed by) CIK: 0001618789 (see all company filings)

IRS No.: 471761992 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89113 | Film No.: 18995160
SIC: 2834 Pharmaceutical Preparations